查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790229

液體栓塞劑市場規模、佔有率和趨勢分析報告：按產品類型、應用、最終用途、地區和細分市場預測，2025 年至 2033 年

Liquid Embolic Agent Market Size, Share & Trends Analysis Report By Product Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

液體栓塞劑市場概況

2024 年全球液體栓塞劑市場規模估計為 2.579 億美元，預計到 2033 年將達到 5.95 億美元，2025 年至 2033 年的複合年成長率為 9.89%。液體栓塞劑產業的主要驅動力是微創手術的進步和全球血管疾病盛行率的不斷上升。

隨著醫療保健系統轉向微創技術，用於治療動脈瘤、動靜脈畸形 (AVM) 和腫瘤等疾病的栓塞劑需求正在激增。神經血管和周邊血管異常及疾病（尤其是動靜脈畸形、硬腦膜動靜脈瘺 (DAVF) 和富血管腫瘤）的增多是市場成長的主要驅動力。根據美國國家生物技術資訊中心發布的一項調查，約 15% 的動靜脈畸形 (AVM) 病例在發生臨床事件之前通常無症狀。 41% 至 79% 的 AVM 與顱內出血有關。 AVM 是繼腦動脈瘤之後第二常見的顱內出血原因，約佔蜘蛛網膜下腔出血的 10%。

兒童比成人更容易出血。典型的出血部位是腦內，但也可能發生在蜘蛛網膜下腔。根據Radiopaedia.org 2024年11月的報告，孤立性動靜脈畸形（AVM）的發生率為98%，多發性動靜脈畸形（AVM）的發生率為2%。因此，AVM病例的增加是推動市場成長的主要因素。

此外，根據美國化學學會2021年4月發布的報告，腦動脈瘤是主要發生在腦血管分支的異常增大。目前，超過60%的動脈瘤採用微創血管內技術治療，例如分流手術和永久性植入金屬囊內彈簧圈。然而，這些現有設備在約20-30%的病例中初始成功率較低，且其整體有效性因動脈瘤的類型和位置而異。因此，這為預測期內液體栓塞劑產業帶來了成長機會。

神經血管栓塞術通常使用液體栓塞Terumo Corporation進行，用於非生物分解乙烯 - 乙烯醇…這些栓塞劑因其能夠有效閉塞異常血管，從而實現高精度和微創治療而廣受歡迎。栓塞劑的選擇取決於具體的臨床情況和病變特徵，持續的技術創新旨在提高介入神經放射學手術的安全性、操作性和長期療效。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 液體栓塞劑市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 液態栓塞劑市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章液體栓塞劑市場：依產品類型估計和趨勢分析

  • 細分儀表板
  • 全球液體栓塞劑市場波動分析
  • 全球液體栓塞劑市場規模及趨勢分析（依產品類型，2021-2033）
  • 乙烯 - 乙烯醇共聚物（EVOH）
  • 氰基丙烯酸酯
  • 其他

第5章液體栓塞劑市場：應用估算與趨勢分析

  • 細分儀表板
  • 全球液體栓塞劑市場波動分析
  • 全球液體栓塞劑市場規模及趨勢分析（按應用，2021-2033）
  • 動靜脈畸形（AVM）
  • 富血管腫瘤
  • 周邊血管出血
  • 其他

6. 液體栓塞劑市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球液體栓塞劑市場波動分析
  • 全球液體栓塞劑市場規模和趨勢分析（按最終用途，2021-2033 年）
  • 醫院
  • 專科診所
  • 門診手術中心（ASC）
  • 其他

7. 液體栓塞劑市場：區域、估計和趨勢分析（按產品類型、應用和最終用途）

  • 區域儀表板
  • 2021-2033 年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024 年主要企業全球市場佔有率分析
    • Johnson & Johnson
    • Medtronic
    • B. Braun SE
    • Terumo
    • Boston Scientific Corporation
    • Balt
    • BlackSwan Vascular, Inc.
    • INVAMED
    • Meril
    • Gem srl
  • 熱圖分析/企業市場分析
  • 2024年企業市場佔有率預測分析
  • 其他主要市場參與企業名單
Product Code: GVR-4-68040-692-5

Liquid Embolic Agent Market Summary

The global liquid embolic agent market size was estimated at USD 257.9 million in 2024 and is projected to reach USD 595.0 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The liquid embolic agent industry is primarily driven by advancements in minimally invasive procedures and the increasing prevalence of vascular diseases worldwide.

As healthcare systems shift towards less invasive techniques, the demand for embolization agents used in treating conditions like aneurysms, arteriovenous malformations (AVMs), and tumors has surged. The growing neurovascular and peripheral vascular abnormalities and diseases such as AVMs, dural arteriovenous fistulas (DAVFs), and hypervascular tumors, among others are primarily driving the market growth. According to a research article published by the National Center for Biotechnology Information, arteriovenous malformations (AVMs) are often asymptomatic in about 15% of cases until a clinical event occurs. Between 41% and 79% of AVMs are present with intracranial hemorrhage. They are the second most common cause of intracranial bleeding after cerebral aneurysms, accounting for approximately 10% of all subarachnoid hemorrhages.

Children are more likely than adults to be present with hemorrhage. While hemorrhages are typically intraparenchymal, they can also primarily occur in the subarachnoid space. In addition, according to an article published by Radiopaedia.org in November 2024, the incidence of solitary AVM is 98% and multiple AVM is 2%. Thus, growing AVM cases are a primary contributor to market growth.

Furthermore, according to an American Chemical Society report published in April 2021, brain aneurysms are abnormal dilations that primarily develop at the branch points of cerebral blood vessels. Over 60% of aneurysms are now managed using minimally invasive endovascular techniques, such as flow diversion or the permanent placement of metallic intrasaccular coils. However, these current devices have an unfavorable primary success rate in approximately 20-30% of cases, and the overall effectiveness varies significantly depending on the aneurysm's type and location. Hence, this brings a growth opportunity for the liquid embolic agent industry during the forecast period.

Neurovascular embolization is commonly performed using liquid embolic agents to treat conditions such as AVMs, DAVFs, and hypervascular tumors. Currently, commonly used liquid embolic agents include n-butyl cyanoacrylate (n-BCA) and ethylene vinyl alcohol copolymer (EVOH) based agents, such as Onyx (Medtronic), Squid (Balt), and PHIL (Terumo), a non-biodegradable iodine-based liquid embolic agent. Additionally, TRUFILL (CERENOVUS, Johnson & Johnson) has recently been introduced. For instance, in March 2024, CERENOVUS, a division of Johnson & Johnson MedTech, announced the launch of the TRUFILL n-BCA Liquid Embolic System Procedural Set. This new offer expands CERENOVUS's hemorrhagic stroke portfolio by providing a comprehensive procedural set that includes two configuration options and all necessary accessories for preparing and delivering the TRUFILL n-BCA Liquid Embolic System. These agents are favored for their ability to effectively occlude abnormal vascular structures, providing minimally invasive treatment options with high precision. The choice of embolic agent depends on the specific clinical scenario and lesion characteristics, with ongoing innovations aiming to improve safety, handling, and long-term efficacy in neurointerventional procedures.

Global Liquid Embolic Agent Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liquid embolic agent market report based on product type, application, end use, and region:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Ethylene Vinyl Alcohol Copolymer (EVOH)
  • Cyanoacrylates
    • N-BCA (n-Butyl Cyanoacrylate)
    • N-HCA (n-Hexyl Cyanoacrylate)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Arteriovenous Malformations (AVM)
  • Hypervascular Tumors
  • Peripheral Vasculature Hemorrhage
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Type
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Liquid Embolic Agent Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence of Vascular Diseases
      • 3.2.1.2. Advancements in Embolization Technologies
      • 3.2.1.3. Growing Preference for Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of agents and materials
      • 3.2.2.2. Risk of complications and adverse events
      • 3.2.2.3. Availability of alternative treatments
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Technological innovations
      • 3.2.3.2. Growing number of clinical trials
      • 3.2.3.3. Expanding application areas
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Regulatory and approval barriers
  • 3.3. Liquid Embolic Agent Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Liquid Embolic Agent Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Liquid Embolic Agent Market Movement Analysis
  • 4.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
  • 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
    • 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cyanoacrylates
    • 4.5.1. Cyanoacrylates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. N-BCA (n-Butyl Cyanoacrylate)
        • 4.5.1.1.1. N-BCA (n-Butyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. N-HCA (n-Hexyl Cyanoacrylate)
        • 4.5.1.2.1. N-HCA (n-Hexyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Liquid Embolic Agent Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Liquid Embolic Agent Market Movement Analysis
  • 5.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Arteriovenous Malformations (AVM)
    • 5.4.1. Arteriovenous Malformations (AVM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hypervascular Tumors
    • 5.5.1. Hypervascular Tumors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Peripheral Vasculature Hemorrhage
    • 5.6.1. Peripheral Vasculature Hemorrhage Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Liquid Embolic Agent Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Liquid Embolic Agent Market Movement Analysis
  • 6.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ambulatory Surgical Centers (ASCs)
    • 6.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Liquid Embolic Agent Market: Regional Estimates & Trend Analysis By Product Type, By Application, By End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Global Key company market share analysis, 2024
    • 8.3.4. Johnson & Johnson
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Terumo
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Balt
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. BlackSwan Vascular, Inc.
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. INVAMED
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Meril
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Gem srl
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2024
  • 8.6. List of Other Key Market Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Liquid Embolic Agent Market, by Region, 2021 - 2033 (USD Million)
  • Table 4. Global Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 5. Global Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. Global Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7. North America Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 9. North America Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 10. North America Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 12. U.S. Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 13. U.S. Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 15. Canada Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 16. Canada Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17. Europe Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 18. Europe Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 19. Europe Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 20. Europe Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21. Germany Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 22. Germany Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 23. Germany Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. UK Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 25. UK Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 26. UK Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27. France Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 28. France Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 29. France Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. Italy Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 31. Italy Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 32. Italy Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Spain Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 34. Spain Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 35. Spain Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Denmark Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 37. Denmark Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 38. Denmark Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39. Sweden Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 40. Sweden Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 41. Sweden Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Norway Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 43. Norway Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 44. Norway Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Asia Pacific Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49. China Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 50. China Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 51. China Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52. Japan Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 53. Japan Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 54. Japan Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55. India Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 56. India Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 57. India Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58. South Korea Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 59. South Korea Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 60. South Korea Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Australia Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 62. Australia Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 63. Australia Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 65. Thailand Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 66. Thailand Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67. Latin America Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 68. Latin America Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 69. Latin America Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 70. Latin America Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71. Brazil Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 72. Brazil Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 73. Brazil Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. Mexico Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 75. Mexico Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 76. Mexico Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 78. Argentina Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 79. Argentina Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 85. South Africa Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 86. South Africa Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 91. UAE Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 92. UAE Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96. Participant's Overview
  • Table 97. Financial Performance
  • Table 98. Product Benchmarking
  • Table 99. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Liquid Embolic Agent Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Liquid Embolic Agent Market, for Ethylene Vinyl Alcohol Copolymer (EVOH), 2021 - 2033 (USD Million)
  • Fig. 15 Global Liquid Embolic Agent Market, for Cyanoacrylates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Liquid Embolic Agent Market, for N-BCA (n-Butyl Cyanoacrylate), 2021 - 2033 (USD Million)
  • Fig. 17 Global Liquid Embolic Agent Market, for N-HCA (n-Hexyl Cyanoacrylate), 2021 - 2033 (USD Million)
  • Fig. 18 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 Global Liquid Embolic Agent Market, for Arteriovenous Malformations (AVM), 2021 - 2033 (USD Million)
  • Fig. 20 Global Liquid Embolic Agent Market, for Hypervascular Tumors, 2021 - 2033 (USD Million)
  • Fig. 21 Global Liquid Embolic Agent Market, for Peripheral Vasculature Hemorrhage, 2021 - 2033 (USD Million)
  • Fig. 22 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 23 Global Liquid Embolic Agent Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 24 Global Liquid Embolic Agent Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 25 Global Liquid Embolic Agent Market, for Ambulatory Surgical Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 26 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 27 Regional Outlook, 2024 & 2033
  • Fig. 28 North America Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 30 Canada Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 31 Europe Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 32 Germany Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 33 UK Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 34 France Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 35 Italy Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 36 Spain Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 37 Denmark Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 38 Sweden Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 39 Norway Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 40 Asia Pacific Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 41 Japan Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 42 China Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 43 India Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 44 Australia Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 45 South Korea Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 46 Thailand Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 47 Latin America Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 48 Brazil Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 49 Mexico Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 50 Argentina Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 51 Middle East and Africa Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 52 South Africa Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 53 Saudi Arabia Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 54 UAE Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 55 Kuwait Liquid Embolic Agent Market, 2021 - 2033 (USD Million)